Compare Cadila Healthcare with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SUN PHARMA CADILA HEALTHCARE/
SUN PHARMA
 
P/E (TTM) x 17.8 31.0 57.4% View Chart
P/BV x 3.2 4.2 77.3% View Chart
Dividend Yield % 0.9 0.9 92.1%  

Financials

 CADILA HEALTHCARE   SUN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-21
SUN PHARMA
Mar-21
CADILA HEALTHCARE/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs509654 77.9%   
Low Rs259339 76.4%   
Sales per share (Unadj.) Rs147.5139.6 105.7%  
Earnings per share (Unadj.) Rs20.99.5 219.3%  
Cash flow per share (Unadj.) Rs28.018.2 153.7%  
Dividends per share (Unadj.) Rs3.507.50 46.7%  
Avg Dividend yield %0.91.5 60.3%  
Book value per share (Unadj.) Rs126.9193.6 65.5%  
Shares outstanding (eoy) m1,023.742,399.34 42.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.63.6 73.2%   
Avg P/E ratio x18.452.1 35.3%  
P/CF ratio (eoy) x13.727.3 50.4%  
Price / Book Value ratio x3.02.6 118.1%  
Dividend payout %16.878.8 21.3%   
Avg Mkt Cap Rs m393,0921,190,430 33.0%   
No. of employees `000NANA-   
Total wages/salary Rs m22,54868,622 32.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m151,022334,981 45.1%  
Other income Rs m4498,592 5.2%   
Total revenues Rs m151,471343,573 44.1%   
Gross profit Rs m31,33541,616 75.3%  
Depreciation Rs m7,24820,800 34.8%   
Interest Rs m1,6881,414 119.4%   
Profit before tax Rs m22,84827,994 81.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4725,147 28.6%   
Profit after tax Rs m21,37622,847 93.6%  
Gross profit margin %20.712.4 167.0%  
Effective tax rate %6.418.4 35.0%   
Net profit margin %14.26.8 207.5%  
BALANCE SHEET DATA
Current assets Rs m87,160304,421 28.6%   
Current liabilities Rs m78,613161,456 48.7%   
Net working cap to sales %5.742.7 13.3%  
Current ratio x1.11.9 58.8%  
Inventory Days Days33149 22.3%  
Debtors Days Days7699 76.6%  
Net fixed assets Rs m140,943336,682 41.9%   
Share capital Rs m1,0242,399 42.7%   
"Free" reserves Rs m128,899462,229 27.9%   
Net worth Rs m129,923464,628 28.0%   
Long term debt Rs m6,0958,981 67.9%   
Total assets Rs m228,103641,103 35.6%  
Interest coverage x14.520.8 69.9%   
Debt to equity ratio x00 242.7%  
Sales to assets ratio x0.70.5 126.7%   
Return on assets %10.13.8 267.2%  
Return on equity %16.54.9 334.6%  
Return on capital %18.06.2 290.5%  
Exports to sales %00-   
Imports to sales %10.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,911NA-   
Fx inflow Rs m63,53584,493 75.2%   
Fx outflow Rs m15,91130,334 52.5%   
Net fx Rs m47,62454,159 87.9%   
CASH FLOW
From Operations Rs m32,93061,704 53.4%  
From Investments Rs m-7,2255,362 -134.7%  
From Financial Activity Rs m-25,489-59,805 42.6%  
Net Cashflow Rs m-9055,964 -15.2%  

Share Holding

Indian Promoters % 74.9 54.5 137.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.7 34.0 46.1%  
FIIs % 3.8 13.0 29.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 45.5 55.2%  
Shareholders   370,931 680,800 54.5%  
Pledged promoter(s) holding % 0.0 4.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 21, 2022 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS